{"name":"Theobromine","slug":"theobromine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["3,7-Dimethylxanthine","Diurobromine","Santheose","Teobromin","Theosalvose","Theostene","Thesal","3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione","Xantheose","FEMA No. 3591"],"brands":[],"scraped":true,"has_structure":true,"cid":5429,"classes":[],"families":[{"name":"xanthine","href":"/substituted/xanthine"}],"physical":[{"label":"Molecular mass","value":"180.16 g/mol","copyable":false},{"label":"Appearance","value":"Monoclinic needles (/crystalline structure is/ lamellar twining on 001 /axis/) from water","copyable":false},{"label":"Taste","value":"Bitter tasting alkaloid","copyable":false},{"label":"Density","value":"1.522 g/cu cm at 20 °C; relative density: 1.522 at 20 °C","copyable":false},{"label":"Melting point","value":"675 °F (NTP, 1992)","copyable":false},{"label":"Boiling point","value":"Sublimes at 554-563 °F (NTP, 1992)","copyable":false},{"label":"Decomposition","value":"Hazardous decomposition products formed under fire conditions - Carbon oxides, nitrogen oxides (NOx).","copyable":false},{"label":"Solubility","value":"less than 1 mg/mL at 64 °F (NTP, 1992)","copyable":false},{"label":"Predicted LogP","value":"-0.8","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>7</sub>H<sub>8</sub>N<sub>4</sub>O<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"3,7-dimethylpurine-2,6-dione","copyable":true},{"label":"SMILES","value":"CN1C=NC2=C1C(=O)NC(=O)N2C","copyable":true},{"label":"InChI","value":"InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)","copyable":true},{"label":"InChIKey","value":"YAPQBXQYLJRXSA-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"83-67-0","copyable":true},{"label":"UNII","value":"OBD445WZ5P","copyable":true},{"label":"PubChem CID","value":"5429","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"6–8 hours<a href=\"#cite_note-3\"><sup>[3]</sup></a><a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false},{"label":"Metabolism","value":"Hepatic demethylation and oxidation","copyable":false},{"label":"Excretion","value":"Renal (10% unchanged, rest as metabolites)","copyable":false},{"label":"Routes of administration","value":"Oral","copyable":false},{"label":"Dependence liability","value":"None","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Dog",[{"kind":"LD50","organism":"Dog","route":"oral","dose":"300 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"C","description":"Cardiovascular system"},{"code":"C03","description":"Diuretics"},{"code":"C03B","description":"Low-ceiling diuretics, excl. thiazides"},{"code":"C03BD","description":"Xanthine derivatives"},{"code":"C03BD01","description":"Theobromine"},{"code":"R","description":"Respiratory system"},{"code":"R03","description":"Drugs for obstructive airway diseases"},{"code":"R03D","description":"Other systemic drugs for obstructive airway diseases"},{"code":"R03DA","description":"Xanthines"},{"code":"R03DA07","description":"Theobromine"}],"mesh":[{"name":"Bronchodilator Agents","id":"M0002975"},{"name":"Vasodilator Agents","id":"M0022559"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Theobromine stimulates medullary, vagal, vasomotor, and respiratory centers, promoting bradycardia, vasoconstriction, and increased respiratory rate. This action was previously believed to be due primarily to increased intracellular cyclic 3&prime;,5&prime;-adenosine monophosphate (cyclic AMP) following inhibition of phosphodiesterase, the enzyme that degrades cyclic AMP. It is now thought that xanthines such as caffeine and theobromine act as antagonist at adenosine-receptors within the plasma membrane of virtually every cell. As adenosine acts as an autocoid, inhibiting the release of neurotransmitters from presynaptic sites but augmenting the actions of norepinephrine or angiotensin, antagonism of adenosine receptors promotes neurotransmitter release. This explains the stimulatory effects of xanthine derivatives such as theobromine and caffeine. Blockade of the adenosine A1 receptor in the heart leads to the accelerated, pronounced \"pounding\" of the heart upon caffeine intake.","side_effects":null,"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Other","status":"In general: Unscheduled.","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Theobromine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5429"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q206844"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01412"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1114"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A28946"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=83-67-0"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0002825"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07480"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9026132"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Theobromine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/OBD445WZ5P"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5429, Theobromine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5429>https://pubchem.ncbi.nlm.nih.gov/compound/5429</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Theobromine. UNII: OBD445WZ5P. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OBD445WZ5P>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OBD445WZ5P</a>","Drouillard DD, Vesell ES, Dvorchik BH. Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthines. Clinical Pharmacology and Therapeutics. March 1978; 23(3):296–302. PMID 627135. <a href='https://doi.org/10.1002/cpt1978233296'>https://doi.org/10.1002/cpt1978233296</a>","Lelo A, Birkett DJ, Robson RA, Miners JO. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. British Journal of Clinical Pharmacology. August 1986; 22(2):177–182. PMID 3756065. <a href='https://doi.org/10.1111/j.1365-2125.1986.tb05246.x'>https://doi.org/10.1111/j.1365-2125.1986.tb05246.x</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 19:41:49","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 19:41:45","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 19:41:45","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 19:41:46","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 19:41:45","note":"hmdb.ca refused automated access to HMDB0002825"},{"source":"kegg","status":"missing","fetched_at":"2026-11-20 19:41:49","note":"no KEGG DRUG entry"},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 19:41:45","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 19:41:45","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 19:41:45","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 19:41:45","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 19:41:45","note":null}],"description":"Theobromine is a  substance."}